Cite
HARVARD Citation
Zhang, S. et al. (2021). Single‐Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK‐788) in Healthy Volunteers: Low‐Fat Meal Effect and Relative Bioavailability of 2 Capsule Products. Clinical pharmacology in drug development. 10 (9), pp. 1028-1043. [Online].